HIV positive patients with end stage renal disease
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2009, Vol 26, Issue 1
Abstract
Five cases of HIV seropositive patients with end stage re-nal disease (ESRD) who were hospitalized, enrolled in the program and received renal replacement therapy in the Nephrology Department for a duration of 6 months to 4 years are presented. All were males, aged 36–59 years. Two of them died (one from infection and the other from cardi-ovascular disease), two are on hemodialysis, and the fifth is living with a functioning kidney graft. All three survivors are living well, without serious problems and are receiving chronic antiretroviral treatment. The management of these patients is reviewed.
Authors and Affiliations
J. DROULIAS, G. METAXATOS, E. POLITIS, C. CHRISTODOULIDOU, K. KOLLIA, V. HADJIKONSTANTINOU
The translation-validation of the sense of coherence scale<br /> into Greek and its use in primary health care
OBJECTIVE Aaron Antonovsky’s Sense of Coherence (SOC) theory tries to explain why some people manage stress and stay well while others break down. According to Antonovsky, a strong SOC helps a person see the world as con...
The treatment threshold probability<br /> after clinical examination in the theory of medical decision making
The treatment threshold probability after clinical examination is by definition the disease probability when the expected value of treatment is equal to the expected value of no treatment-“attentive waiting”. The outcome...
Male breast cancer
No abstract available
Severe acute respiratory syndrome (SARS):<br /> An opportunity for lessons in public health
During the spring of 2003, a new clinical entity, the severe acute respiratory syndrome (SARS), constituted a head line subject for the mass media and public opinion worldwide because of the rapid spread of the disease t...
In vitro hepatitis C virus replication systems and novel therapeutic agents for chronic hepatitis C
Until recently, due to the lack of an effective cell culture system for the Hepatitis C Virus (HCV), the design of novel therapeutic agents was difficult. The recent progress in the molecular virology of HCV has created...